Show results for
Refine by
Pharmacokinetic Suppliers Serving Canada
65 companies found
based inHercules, CALIFORNIA (USA)
Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products ...
Antibodies for bioanalysis and drug monitoring of adalimumab and biosimilars. Develop highly selective and sensitive PK and ADA assays for adalimumab (Humira) using our range of ready-made anti-idiotypic antibodies. Highly specific to adalimumab or ...
based inNangang Distric, TAIWAN
We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ...
Studies by X. Yao et al and S. Perinel et al suggest that HCQ can prevent the acidification of intracellular organelles, inhibit lysosomal release of viral genome and interfere with the glycosylation of the angiotensin-converting enzyme-2 (ACE2) ...
based inHamburg, GERMANY
Eurofins bioskin is a full-service CRO specialized in dermatology which provides strategic and regulatory consulting for dermatology and related products, early phase human safety and Proof-of-Concept studies, vasoconstrictor assays according to FDA ...
Investigation of cutaneous safety is a critical component of product development for topical and systemic products and transdermal systems. At bioskin we are experienced in the design and conduct of the entire spectra of cutaneous safety studies and ...
based inPasadena, CALIFORNIA (USA)
Bench Chemicals, aka. BenchChem, is a leading supplier of high-quality chemicals and biochemicals for laboratory and R&D use. Our mission is to provide scientists and researchers worldwide with a one-stop source for innovative and basic chemicals ...
Nevadensin is a novel small molecule that has been studied for its potential therapeutic applications in medicine. It is a member of the polyphenol family and has a unique structure that makes it attractive for use in various medical applications. ...
based inParis, FRANCE
The Bioprojet company was founded in 1982 under the impetus of Jeanne-Marie Lecomte and Jean-Charles Schwartz, doctors of pharmacy and sciences. From very different backgrounds, Jeanne-Marie Lecomte made her career in the pharmaceutical industry, ...
based inNew Market, MARYLAND (USA)
FiberCell Systems specializes in innovative cell culture technology, offering advanced solutions for a wide array of applications, including the production of recombinant proteins, monoclonal antibodies, antibiotic pharmacokinetics/pharmacodynamics ...
based inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
DEP® docetaxel is an enhanced version of docetaxel (Taxotere®) – widely used for breast, lung & prostate cancer. Docetaxel (Taxotere®) is a commonly used chemotherapy agent despite having multiple US FDA “Black Box” ...
based inKrakow, POLAND
We are one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. We have ...
Having experience in both pharma and biotech R&D, we are well aware of what it means to discover a hit and transform it into a drug. You can best benefit from this “insider” experience through our integrated drug discovery services ...
based inDublin 4, IRELAND
Alkermes is focused on developing innovative medicines that aim to address unmet needs of people living with serious mental illness, addiction and cancer. As a fully-integrated global biopharmaceutical company, we apply our scientific expertise and ...
ARISTADA® (aripiprazole lauroxil) extended-release injectable suspension is a long-acting atypical antipsychotic that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults. ARISTADA is available ...
based inLund, SWEDEN
Emmace is an industry leader in the field of Contract Research Organisation (CRO) services, focusing on the development and optimization of orally inhaled and nasal drug products. With a strong emphasis on improving global health standards, Emmace ...
The software is a comprehensive tool that not only simulates how particles deposit in various regions of the lungs but also integrates pharmacokinetic (PK) simulations to predict how these particles are absorbed, distributed, ...
based inGaithersburg, MARYLAND (USA)
As a global life sciences company, Emergent offers specialized products to healthcare providers and governments to address medical needs and emerging health threats. Protecting and Enhancing 50 million lives by 2025 focuses our energy to improve the ...
Raxibacumab is indicated for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs. Raxibacumab is also indicated for prophylaxis of inhalational anthrax ...
based inTübingen, GERMANY
Founded in 2015, Atriva Therapeutics is a biopharmaceutical company specifically pioneering the development of host-targeting antiviral therapies set up by a team of leading scientists in viral research and seasoned industry experts. The company ...
The company’s lead drug candidate is the MEK inhibitor zapnometinib. The small molecule, which can be administered orally (tablet), is under advanced clinical development in two severe respiratory viral diseases: COVID-19 and influenza, two ...
based inCambridge, MASSACHUSETTS (USA)
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer. Leveraging decades of industry learnings, we have developed proprietary and highly ...
Immunosynthen is our novel immunostimulatory ADC platform designed to take ADCs beyond traditional cytotoxic drugs to targeted stimulation of the innate immune system. Through the safe and efficient delivery of a novel immunomodulatory STING ...
based inSilver Spring, MARYLAND (USA)
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical ...
TYVASO (treprostinil) is a prostacyclin mimetic indicated for the treatment of: Pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies establishing effectiveness predominately included patients with NYHA Functional ...
based inNew York, NEW YORK (USA)
Creative Peptides is specialized in the process development and the manufacturing of bioactive peptides. We are dedicated to offering custom peptide synthesis, process development, GMP manufacturing as well as catalog products for customers in ...
based inRoden, NETHERLANDS
Pure Inhalation Medication Systems (PureIMS) is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops. The focus is on the treatment of ...
Amikacin Cyclops™ is an amikacin dry powder inhaler for the treatment of tuberculosis (TB). Inhaled amikacin from the Cyclops™ will result in higher amikacin concentrations in the lungs than conventional infusion or intramuscular ...
based inMississauga, ONTARIO (CANADA)
Intrinsik Inc. is a private, employee owned company with over 20 years of experience in environmental and health consulting. We are recognized as a leader in toxicology, risk assessment, and risk management consultation in Canada and around the ...
based inBerlin, GERMANY
MerLion Pharmaceuticals is a biopharma company focusing on the research and development of drugs for the treatment of serious bacterial infections. MerLion - located in Berlin-Buch, Germany - manages the non-clinical and clinical development as well ...
Finafloxacin is a novel candidate for the treatment of multiple, life-threatening infection indications, like complicated urinary tract infections (cUTIs). Coming from a well-known and well understood “workhorse” class of antibiotic, its ...
based inGöteborg, SWEDEN
Getinge is a global medical technology company, founded in Sweden in 1904. The firm provides equipment and systems within healthcare and life sciences. Getinge Infection Control (GETINGE) is one out of three business areas within Getinge AB, a ...
Advanced anesthesia for all procedures, from neonates to the morbidly obese. The Flow-i combines superior ventilation performance with smart decision support tools in an easy to use workstation. The Flow-i lets you treat even your most ...
based inNaarden, NETHERLANDS
Azafaros has leveraged on decades of discovery by professors Hans Aerts, Hermen Overkleeft, and Stan van Boeckel at Leiden University and the Academic Medical Center in the Netherlands. Expanding on their research and led by highly experienced ...
Azafaros B.V. is pioneering the development of innovative oral small molecule compounds addressing the pathological effects of metabolite accumulation in rare metabolic disorders. Their lead compound, nizubaglustat, leverages unique dual-mode ...